Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes / Matsumura, N; Zordoky, Bn; Robertson, Im; Hamza, Sm; Parajuli, N; Soltys, Clm; Beker, Dl; Grant, Mk; Razzoli, M; Bartolomucci, A; Dyck, Jrb. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - 114:(2018), p. 1350-1359.

Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.

Bartolomucci A;
2018-01-01

2018
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes / Matsumura, N; Zordoky, Bn; Robertson, Im; Hamza, Sm; Parajuli, N; Soltys, Clm; Beker, Dl; Grant, Mk; Razzoli, M; Bartolomucci, A; Dyck, Jrb. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - 114:(2018), p. 1350-1359.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2911363
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 38
social impact